Breast Cancer Clinical Trials
Breast Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for breast Cancer. Corterve aggregates actively recruiting Breast Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Breast Cancer studies
- Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast CancerNCT07652242PHASE1Immunomic Therapeutics, Inc.Grand Rapids, Michigan
- Evaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryNCT07686250PHASE2H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerNCT03606967PHASE2National Cancer Institute (NCI)Orange, California
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisNCT01441089National Cancer Institute (NCI)Bethesda, Maryland
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerNCT06058377PHASE3National Cancer Institute (NCI)Birmingham, Alabama
- A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast CancerNCT04521764PHASE1Mayo ClinicRochester, Minnesota
- Evolutionary Clinical Trial for Novel Biomarker-Driven TherapiesNCT07340541PHASE2UNC Lineberger Comprehensive Cancer CenterNew Haven, Connecticut
- Prevention of Frailty With Fisetin and Exercise in Breast Cancer SurvivorsNCT06113016PHASE2Jonsson Comprehensive Cancer CenterAlhambra, California
- Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T CellsNCT06347068PHASE1UNC Lineberger Comprehensive Cancer CenterChapel Hill, North Carolina
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialNCT05564377PHASE2National Cancer Institute (NCI)Birmingham, Alabama
- Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsNCT04222413PHASE1National Cancer Institute (NCI)Fairway, Kansas
- A Phase 1 of CTX-8371 in Patients With Advanced MalignanciesNCT06150664PHASE1Compass TherapeuticsMargate, Florida
Breast Cancer trials by state
Breast Cancer trials by metro
Frequently asked questions
- How do I find recruiting Breast Cancer clinical trials?
- Corterve aggregates actively recruiting Breast Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Breast Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Breast Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.